Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 2
1987 2
1988 2
1989 2
1991 1
1992 3
1993 1
1994 2
1995 5
1997 1
1998 5
1999 2
2000 5
2002 2
2003 2
2005 1
2006 2
2007 2
2008 2
2009 7
2010 8
2011 3
2012 2
2015 4
2019 1
2020 4
2021 6
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

76 results
Results by year
Filters applied: . Clear all
Page 1
The control of mitosis.
Hixon ML, Gualberto A. Hixon ML, et al. Among authors: gualberto a. Front Biosci. 2000 Jan 1;5:D50-7. doi: 10.2741/hixon. Front Biosci. 2000. PMID: 10702375 Free article. Review.
Figitumumab (CP-751,871) for cancer therapy.
Gualberto A. Gualberto A. Expert Opin Biol Ther. 2010 Apr;10(4):575-85. doi: 10.1517/14712591003689980. Expert Opin Biol Ther. 2010. PMID: 20175655 Review.
The Weight of Obesity in Immunity from Influenza to COVID-19.
Andrade FB, Gualberto A, Rezende C, Percegoni N, Gameiro J, Hottz ED. Andrade FB, et al. Among authors: gualberto a. Front Cell Infect Microbiol. 2021 Mar 17;11:638852. doi: 10.3389/fcimb.2021.638852. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 33816341 Free PMC article. Review.
Genomic instability and cancer.
Tlsty TD, Briot A, Gualberto A, Hall I, Hess S, Hixon M, Kuppuswamy D, Romanov S, Sage M, White A. Tlsty TD, et al. Among authors: gualberto a. Mutat Res. 1995 Jul;337(1):1-7. doi: 10.1016/0921-8777(95)00016-d. Mutat Res. 1995. PMID: 7596354 Review. No abstract available.
Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers.
Rodríguez M, Alonso-Alonso R, Tomás-Roca L, Rodríguez-Pinilla SM, Manso-Alonso R, Cereceda L, Borregón J, Villaescusa T, Córdoba R, Sánchez-Beato M, Fernández-Miranda I, Betancor I, Bárcena C, García JF, Mollejo M, García-Cosio M, Martin-Acosta P, Climent F, Caballero D, de la Fuente L, Mínguez P, Kessler L, Scholz C, Gualberto A, Mondéjar R, Piris MA. Rodríguez M, et al. Among authors: gualberto a. Blood Adv. 2021 Dec 28;5(24):5588-5598. doi: 10.1182/bloodadvances.2021005171. Blood Adv. 2021. PMID: 34592752 Free PMC article.
Development of inhibitors of the IGF-IR/PI3K/Akt/mTOR pathway.
Hixon ML, Paccagnella L, Millham R, Perez-Olle R, Gualberto A. Hixon ML, et al. Among authors: gualberto a. Rev Recent Clin Trials. 2010 Sep;5(3):189-208. doi: 10.2174/157488710792007329. Rev Recent Clin Trials. 2010. PMID: 20533896 Review.
Tipifarnib as a Precision Therapy for HRAS-Mutant Head and Neck Squamous Cell Carcinomas.
Gilardi M, Wang Z, Proietto M, Chillà A, Calleja-Valera JL, Goto Y, Vanoni M, Janes MR, Mikulski Z, Gualberto A, Molinolo AA, Ferrara N, Gutkind JS, Burrows F. Gilardi M, et al. Among authors: gualberto a. Mol Cancer Ther. 2020 Sep;19(9):1784-1796. doi: 10.1158/1535-7163.MCT-19-0958. Epub 2020 Jul 29. Mol Cancer Ther. 2020. PMID: 32727882 Free PMC article.
76 results